digiM AAPS Topical and Transdermal Community 2024

Microstructure CQAs
Full field-of-view pharmaceutical tablet microstructure image showing internal phase distribution and pore network

Formulation development and optimization of topical dosage forms often involves some guesswork with selecting formulation and process parameters. Globule characterization can play a pivotal role in offering insights for innovators and generic formulators during the development lifecycle of topical products. Globules within topical products can be achieved through the use of high-resolution 3D X-ray micro-CT, with AI analysis enabling the inspection of products in their native states.

Key Learning Objectives:

  • What globule attributes can we quantify with non-invasive analysis?
  • How can we assess Q3 bioequivalence for topical products?
  • How can these CQAs accelerate process and formulation selection? 
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

A purple tablet dissolving